Please login to the form below
J&J adds Manchester to partnering network
Adds satellite office for London innovation hub
GSK raises stake in Indian subsidiary
Company eyes long-term growth of market
Pharma payments to US doctors down
Follows intensified public scrutiny and introduction of the Sunshine Act
Draftfcb Healthcare rebrands and acquires Halesway
The US agency will operate as FCB Health
FDA scrutiny of alirocumab hits Regeneron and Sanofi
Regulator to assess neurocognitive effects of cholesterol drug
EMA to restrict use of domperidone and diacerein
Regulator's pharmacovigilance advisors also want insomnia drug zolpidem's labelling tightened up
New data puts Jakafi on course for blockbuster status
Novartis/Incyte drug meets targets in blood cancer trial
Pfizer recalls depression drug in US
Wrong medicine found in bottle of Effexor XR
Translational pharmacology: the key to ensuring safe and effective dosing
Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success
-
Use data responsiblyIt’s imperative that opening up clinical trial data doesn’t compromise patient safety
-
Pharma’s four options for innovationOnly genuinely creative companies will profit from the future
-
J&J gets EU green light for novel TB drugSirturo approved to treat multidrug resistant form of the disease
-
Novartis' dermatology plans advance with Xolair approvalGreen light for use in chronic spontaneous urticaria
-
Diabetes awards programme launchesQiC Diabetes 2014 premiered at Diabetes UK conference
-
INC Research acquires Middle Eastern CRO
Purchase of MEK Consulting expands its geographic footprint
-
BMS' novel HIV drug clears phase II trialEntry inhibitor BMS-660368 moves closer to first-in-class approval
-
Lilly/Boehringer's empagliflozin faces US approval delayFDA cites manufacturing issues with the new diabetes drug
-
UDG buys KnowledgePoint360’s comms businessDeal is worth $144m
Latest appointments
-
Isgro boosts senior teamBettina Weber joins German communications agency
-
Roche appoints new oncology research headWilliam Pao leaves academia for pharma role
-
Oxford Pharmascience adds to boardJohn Goddard is former head of group strategic planning and business at AstraZeneca
-
Stallergenes appoints Christian Chavy CEOHe will replace Roberto Gradnik at the end of this month
-
New VP for Merz North AmericaGregory Bass to lead market access and reimbursement strategy
Featured jobs
- Account Associate
- On application
- Account Director - Medical Education
- Competitive + excellent benefits
- Senior Account Executive / Account Manager - Healthcare Advertising - London
- £30000 - £39000 + Bonus + Benefits
- Account Manager - Healthcare PR/ Comms
- £Competitive + excellent benefits
- Brand Manager - Oncology - South East
- Excellent Basic, Bonus and Benefits
- Marketing Manager UK & Ireland - Bagshot, Surrey
- Circa £60,000 + benefits
- Account Manager / (Senior) Analyst – Market Access
- Up to £45,000 plus bonus
- Account Director
- up to 60k
- Client Director, Healthcare, Dublin
- Competitive salary, plus benefits
- Senior Production Editor opportunity in Oxfordshire. Salary up to £65, 000.
- Salary up to £65,000
- Business Development Director
- Competitive Salary Offered
- Account Director – PR Healthcare
- Excellent salary and package
- Account Director- Healthcare
- Highly Competitive Salary
Subscribe to our email news alerts
PMHub
Red Door Communications
Red Door Communications (RDC) is the health and wellbeing communications consultancy that lives and breathes originality and is built on...
Latest intelligence
- NICE and ‘ultra orphans’
- NICE and its processes for ‘highly specialised therapies’...
- Trust is key to online engagement
- In social media it underlines the value of HCP networks...
- Compulsory evaluation in France
- French authorities will expect robust health economic cases to be made for some drugs...
Quick links
